All News

With surgical techniques applicable to many stages of kidney cancer, it is important for patients to discuss these options with their cancer team to select the best approach for their disease.

Becoming an advocate after my cancer diagnosis made an impact not only on others, but for myself.

Patients experiencing chemotherapy-related cognitive impairment may forget where they put things or even stop paying their bills, an expert said.

The Food and Drug Administration approved Reblozyl to treat low red blood cell count in patients with very low- to intermediate-risk myelodysplastic syndrome.

It’s been a long road since being diagnosed with melanoma in early 2020.

When asked for recommended treatments for certain types of cancer, ChatGPT missed the mark about one-third of the time, research showed.

Here's how I learned to talk about my cancer.

Elrexfio has been shown to provide patients with relapsed/refractory multiple myeloma who previously received four or more lines of therapy with a response that may last at least 15 months, an expert explained.

Nurse practitioner Charina Toste explains why it is important for patients to be empowered to have educated conversation with their care teams.

Constantly replaying scary cancer situations or drowning in anxiety isn’t only depressing it wastes valuable energy that could be used for healing.

Final study analysis of the TROPiCS-02 trial support Trodelvy as “a standard treatment” for patients.

A phase 3 trial shows that zolbetuximab improved survival in patients with advanced gastric or gastroesophageal junction cancer.

Jemperli plus chemotherapy has been approved for the treatment of adults with primary advanced or recurrent mismatch repair deficient (dMMR) or microsatellite instability-high endometrial cancer.

Someone was watching over me the day I was diagnosed with non-small cell lung cancer.

From a former patient with cancer lives her dream of working alongside her doctor, to NASCAR crew chief Tommy Baldwin Jr. announcing his cancer diagnosis, this is what’s going on in the oncology space this week.

Progression-free survival improved with Retevmo as the initial treatment for patients with advanced RET-mutant medullary thyroid cancer.

Cancer survivors who consume alcohol may experience worse outcomes, as alcohol usage can interfere with treatment results.

The recent FDA approval of Talvey for heavily pretreated multiple myeloma results in an improved response to therapy and a manageable side effect profile.

Once a friendship turned toxic, I had to put myself first.

“I treat all of my patients like my friends and family,” said Dr. Ravi Munver of Hackensack University Medical Center, who first met Peter Kahan as his honors physics teacher more than 35 years ago.

Cancer survivors who received care plans were more likely to regularly attend cancer-related follow-up care visits, researchers found.

As part of its Speaking Out video series, CURE spoke with Nikki Yuill, oncology social worker and director of the Leukemia & Lymphoma Society’s Information Resource Center, about some of the challenges faced by patients.

As part of its Speaking Out video series, CURE spoke with Dr. Lee Greenberger, chief scientific officer of the Leukemia & Lymphoma Society, about the current research in treatments.

As part of its Speaking Out video series, CURE spoke with Dr. Lee Greenberger, chief scientific officer of the Leukemia & Lymphoma Society, who discussed recent treatment advancements and FDA approvals.

As part of its Speaking Out video series, CURE spoke with Nikki Yuill, oncology social worker and director of the Leukemia & Lymphoma Society’s Information Resource Center, about some of the challenges faced by patients.

As part of its Speaking Out video series, CURE spoke with Nikki Yuill, oncology social worker and director of the Leukemia & Lymphoma Society’s Information Resource Center, about some of the challenges faced by patients.

The Oncologic Drug Advisory Committee will review data to determine if Lumakras should gain FDA approval for certain patients with KRAS G12C-mutant non-small cell lung cancer.

I became a frequent shopper at the hospital gift shop throughout my cancer experience.